Aurisco Pharmaceutical Co.,Ltd. (SHA:605116)
China
· Delayed Price · Currency is CNY 21.56
+0.65 (3.11%)
May 16, 2025, 3:00 PM CST
Aurisco Pharmaceutical Revenue
Aurisco Pharmaceutical had revenue of 402.00M CNY in the quarter ending March 31, 2025, with 19.78% growth. This brings the company's revenue in the last twelve months to 1.54B, up 18.99% year-over-year. In the year 2024, Aurisco Pharmaceutical had annual revenue of 1.48B with 16.89% growth.
Revenue (ttm)
1.54B
Revenue Growth
+18.99%
P/S Ratio
5.68
Revenue / Employee
864.41K
Employees
1,521
Market Cap
8.76B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Aier Eye Hospital Group | 21.81B |
| Shanghai United Imaging Healthcare | 10.43B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |